Collaborative network of predictive markers complicates formation of prognostic groups in patients with advanced lung cancer

Anticancer Research

Volumn 34, Issue 6, 2014, Pages 2745-2754

  Schwab, Bernice ^a   Rudolph, Andreas ^b   Jost, Edgar ^c   Klinge, Uwe ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b BUNDESWEHR UNIVERSITY MUNICH   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Collaborative network; Non small cell lung cancer; Predictive tumor markers

Indexed keywords

CA 15-3 ANTIGEN; CA 19-9 ANTIGEN; CA 72-4 ANTIGEN; CYCLOOXYGENASE 2; CYTOKERATIN 19 FRAGMENT; GELATINASE A; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADVANCED CANCER; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER PROGNOSIS; CANCER STAGING; CLINICAL ARTICLE; DECISION TREE; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; LUNG ADENOCARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; MALE; MEDICAL RECORD REVIEW; NON SMALL CELL LUNG CANCER; RETROSPECTIVE STUDY; BONE TUMOR; BRAIN TUMOR; COHORT ANALYSIS; COLLABORATIVE NETWORK; FOLLOW UP; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; NON-SMALL CELL LUNG CANCER; PATHOLOGY; PREDICTIVE TUMOR MARKERS; PREDICTIVE VALUE; SQUAMOUS CELL CARCINOMA; STATISTICAL MODEL; SURVIVAL RATE; TUMOR RECURRENCE;

COLLABORATIVE NETWORK; NON-SMALL CELL LUNG CANCER; PREDICTIVE TUMOR MARKERS;

BONE NEOPLASMS; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84906311557     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Billroth T: Chirurgische Erfahrungen, Zürich 1860-1867 Langenbecks Arch Chir 10: 1-113, 1869.
2. Breimann L, Friedmann JH, Ohlson RA and Stone CJ: Classification and Regression Trees: Belmont, CA, Wadsworth International Group, 1984.
3. Chen DT, Hsu YL, Fulp WJ, Coppola D, Haura EB, Yeatman TJ and Cress WD: Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer. J Natl Cancer Inst 103: 1859-1870, 2011.
4. Dai J, Hu Z, Dong J, Xu L, Pan S, Jiang Y, Jin G, Chen Y and Shen H: Host immune gene polymorphisms were associated with the prognosis of non-small-cell lung cancer in Chinese. Int J Cancer 130: 671-676, 2012.
5. de Fraipont F, Levallet G, Creveuil C, Bergot E, Beau-Faller M, Mounawar M, Richard N, Antoine M, Rouquette I, Favrot MC, Debieuvre D, Braun D, Westeel V, Quoix E, Brambilla E, Hainaut P, Moro-Sibilot D, Morin F, Milleron B and Zalcman G: An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial. Clin Cancer Res 18: 2976-2986, 2012.
6. Dehing-Oberije C, Aerts H, Yu S, De Ruysscher D, Menheere P, Hilvo M, van der Weide H, Rao B and Lambin P: Development and validation of a prognostic model using blood biomarker information for prediction of survival of non-small-cell lung cancer patients treated with combined chemotherapy and radiation or radiotherapy alone (NCT00181519, NCT00573040, and NCT00572325). Int J Radiat Oncol Biol Phys 81: 360-368, 2011.
7. Di Maio M, Krzakowski M, Fougeray R, Kowalski DM and Gridelli C: Prognostic score for second-line chemotherapy of advanced non-small-cell lung cancer: external validation in a phase III trial comparing vinflunine with docetaxel. Lung Cancer 77: 116-120, 2012.
8. Geman S, Bienenstock E and Doursat R: Neural networks and the bias/variance dilemma. Neural Computation 4: 1-58, 1992.
9. Gigerenzer G and Brighton H: Homo Heuristicus: Why Biased Minds Make Better Inferences. Topics in Cognitive Science 1: 107-143, 2009.
10. Grenander U: On empirical spectral analysis of stochastic processes. Ark Matemat 1: 503-531, 1951.
11. Hu J, Liu YL, Piao SL, Yang DD, Yang YM and Cai L: Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer. Lung Cancer 77: 593-599, 2012.
12. Kossler W, Fiebeler A, Willms A, ElAidi T, Klosterhalfen B and Klinge U: Formation of translational risk score based on correlation coefficients as an alternative to Cox regression models for predicting outcome in patients with NSCLC. Theor Biol Med Model 8: 28, 2011.
13. Kuo YW, Jerng JS, Shih JY, Chen KY, Yu CJ and Yang PC: The prognostic value of the simplified comorbidity score in the treatment of small cell lung carcinoma. J Thorac Oncol 6: 378-383, 2011.
14. Liu H, Zhang T, Ye J, Li H, Huang J, Li X, Wu B, Huang X and Hou J: Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer. Cancer Immunol Immunother, 2012.
15. Lopez-Encuentra A, Lopez-Rios F, Conde E, Garcia-Lujan R, Suarez-Gauthier A, Manes N, Renedo G, Duque-Medina JL, Garcia-Lagarto E, Rami-Porta R, Gonzalez-Pont G, Astudillo-Pombo J, Mate-Sanz JL, Freixinet J, Romero-Saavedra T, Sanchez-Cespedes M and Gomez de la Camara A: Composite anatomical-clinical-molecular prognostic model in non-small cell lung cancer. Eur Respir J 37: 136-142, 2011.
16. Mountain CF: Staging of lung cancer. Yale J Biol Med 54: 161-172, 1981.
17. Navarro A, Diaz T, Gallardo E, Vinolas N, Marrades RM, Gel B, Campayo M, Quera A, Bandres E, Garcia-Foncillas J, Ramirez J and Monzo M: Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer. J Surg Oncol 103: 411-415, 2011.
18. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET and Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5: 649-655, 1982.
19. Remmele W, Hildebrand U, Hienz HA, Klein PJ, Vierbuchen M, Behnken LJ, Heicke B and Scheidt E: Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer. Virchows Arch A Pathol Anat Histopathol 409: 127-147, 1986.
20. Tutz G: Die Analyse kategorialer Daten: Oldenbourg, 2000.
21. Wan YW, Beer DG and Guo NL: Signaling pathway-based identification of extensive prognostic gene signatures for lung adenocarcinoma. Lung Cancer 76: 98-105, 2012.
22. Wu DW, Cheng YW, Wang J, Chen CY and Lee H: Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting. Cancer Res 70: 10392-10401, 2010.
23. Zhang H and Singer BH: Recursive Partitioning and Applications: Springer, 2010.